bluebird bio
BLUE
#9804
Rank
NZ$84.18 M
Marketcap
NZ$8.60
Share price
0.00%
Change (1 day)
-75.31%
Change (1 year)

Market capitalization of bluebird bio (BLUE)

Last known market cap: NZ$84.18 Million

As of December 2025 bluebird bio has a market cap of NZ$84.18 Million. This makes bluebird bio the world's 9804th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of bluebird bio from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$84.18 M-41.48%
2024NZ$0.14 B-65.8%
2023NZ$0.42 B-53.46%
2022NZ$0.90 B-11.87%
2021NZ$1.02 B-74.24%
2020NZ$3.98 B-44.83%
2019NZ$7.21 B-10.88%
2018NZ$8.09 B-34.22%
2017NZ$12.30 B270.37%
2016NZ$3.32 B-4.02%
2015NZ$3.46 B-8.56%
2014NZ$3.78 B519.4%
2013NZ$0.61 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
NZ$17.85 B 21,113.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.90 B 22,361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$201.94 B 239,786.79%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
NZ$0.29 B 247.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$418.60 B 497,162.31%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
NZ$17.52 M-79.18%๐Ÿ‡บ๐Ÿ‡ธ USA